Shanghai, China

Yanhang Liu

This inventor holds 2 USPTO granted patents. Top assignees: 280 Bio, Inc., Shanghai Yingli Pharmaceutical Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yanhang Liu. Retrieved from https://idiyas.com/inventor/yanhang-liu-kzlt5ni6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yanhang Liu: Innovator in Pharmaceutical Chemistry

Introduction

Yanhang Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and patent applications.

Latest Patents

Yanhang Liu holds a patent for a compound containing a structure of a five-membered heteroaromatic ring. This patent, titled "Compound containing structure of a five-membered heteroaromatic ring, pharmaceutical compositions thereof and applications thereof," discloses a compound that is expected to treat and/or prevent various PARG-related diseases. The pharmaceutical compositions derived from this compound are anticipated to have significant therapeutic applications.

Career Highlights

Yanhang Liu is currently associated with 280 Bio, Inc., where he continues to advance his research in pharmaceutical innovations. His work focuses on developing new compounds that can address critical health issues.

Collaborations

Yanhang Liu collaborates with notable colleagues, including Zusheng Xu and Yangtong Lou, who contribute to his research endeavors and help drive innovation in their field.

Conclusion

Yanhang Liu's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work is expected to have a lasting impact on the treatment of PARG-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…